Guide · Updated November 2026

Ozempic without insurance for people with type 2 diabetes (late 2026): prices, Medicare rules and 12-month costs

Released: November 9, 2026 · Last reviewed: November 9, 2026

How much does Ozempic cost without insurance in late 2026?

The pen costs $349 or $499 a month through NovoCare, depending on dose. NovoCare defines one month as "1 box of 1 Ozempic® pen."

New patients start lower. NovoCare's terms say patients new to the Ozempic Savings Offer or NovoCare home delivery "pay $199 for each month of 0.25 mg and 0.5 mg. Offer for 2 monthly fills through December 31, 2026."

The Ozempic pill is cheaper per month: $149 to $299 by dose on NovoCare's price selector.

One catch applies to every self-pay price. NovoCare says a self-pay prescription "will not count toward any deductibles, and cannot be applied to any insurance maximum out-of-pocket limits."

What doses does Ozempic come in, and which one will you pay for?

Ozempic's prescribing information (revised May 2026) starts you at 0.25 mg once weekly for 4 weeks, then 0.5 mg. "The recommended maintenance dosage is 0.5 mg, 1 mg, or 2 mg," chosen "based on glycemic control," and "the maximum recommended dosage is 2 mg once weekly." For adults with type 2 diabetes and chronic kidney disease, the label's maintenance dosage is 1 mg.

Your maintenance dose sets your price. Moving to 2 mg adds $499 − $349 = $150 a month, or $150 × 12 = $1,800 a year. That decision rests on your blood sugar, not the price list.

The pill works differently. Its label says the 1.5 mg starting dose, taken for the first 30 days, "is not effective for glycemic control." You then move to 4 mg, and to 9 mg if you need more glucose control. So the $149 price usually covers a single month; the ongoing self-pay price is $199 or $299.

Does the Medicare GLP-1 Bridge cover Ozempic for type 2 diabetes?

No. Medicare.gov lists three drugs under the Medicare GLP-1 Bridge: Foundayo (tablet), Wegovy (injection or tablet) and Zepbound (KwikPen only). Ozempic is not on the list. The Bridge runs from July 1, 2026 to December 31, 2027, with a $50 copayment for a one-month supply.

To qualify, you must be 18 or older and have a BMI of 35 or higher; a BMI of 30 or higher with diastolic heart failure, uncontrolled high blood pressure or chronic kidney disease stage 3a or higher; or a BMI of 27 or higher with prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease.

Medicare.gov then says you aren't eligible if you "Have type 2 diabetes, moderate-to-severe sleep apnea, or fatty liver disease (but your Part D plan might cover your GLP-1s)." Its eligibility checker tells people who answer yes that "your Medicare drug plan should cover GLP-1 medications to treat these conditions."

CMS explains why on its provider page. The Bridge "was designed to increase access to GLP-1s for beneficiaries who seek the drug solely to reduce excess body weight or maintain weight reduction," while type 2 diabetes is among the indications that "are eligible for Part D coverage."

So with Medicare and type 2 diabetes, your route to Ozempic is your Part D plan's formulary, not the Bridge. "Might cover" and "should cover" are not promises, so check your plan's formulary and prior authorization rules.

Can you pay NovoCare's cash price if you have Medicare?

Yes, with limits. NovoCare says "Government-insured patients may use this program if they self pay and process outside of their insurance." It tells pharmacists to advise Medicare Part D patients that the purchase must not be counted toward "Medicare Part D True Out-of-Pocket Costs (TrOOP)." The $25 savings card is a different program, and its terms say "Government beneficiaries excluded."

So cash paid at $349 a month does nothing toward your Part D out-of-pocket limit. Compare your plan's copay first.

What if you have commercial insurance that covers Ozempic?

NovoCare's savings offer says you can "pay as little as $25, subject to a maximum savings of $100/month." What you pay depends on your plan's copay:

• Copay of $125: $125 − $100 = $25 a month.
• Copay of $300: $300 − $100 = $200 a month, still below the $349 cash price.
• Copay of $500: $500 − $100 = $400 a month. Here cash at $349 is $51 less per fill, but cash payments won't count toward your deductible.

Novo's Q3 2026 report adds a dated change. On January 1, 2027, Novo will lower the list price of Ozempic injection 0.5 mg, 1 mg and 2 mg, and of Ozempic pill tablets at the strengths the report names (7 mg or 14 mg), to USD 675, a reduction of approximately 35% for Ozempic. If your plan charges coinsurance, or you are still meeting a deductible, your cost may change in January.

Is Rybelsus still available, and what does the pill cost?

Rybelsus is being phased out under that name. NovoCare's Rybelsus page says "RYBELSUS® is being replaced by Ozempic® pill" and that Ozempic pill "will have the same coverage as RYBELSUS®." Novo made Ozempic pill available nationwide in the U.S. on May 4, 2026.

The tablets use different strengths. The shared prescribing information pairs Rybelsus 7 mg with Ozempic tablets 4 mg, and Rybelsus 14 mg with Ozempic tablets 9 mg, for people switching after the first 30 days. Those cost $199 and $299 a month at NovoCare; we found no separate Rybelsus self-pay price.

What does a year of Ozempic cost compared with other options?

Worked example 1: a dose change on the pen

A year at 1 mg costs 12 × $349 = $4,188. If your clinician moves you to 2 mg after three months, the year costs 3 × $349 + 9 × $499 = $1,047 + $4,491 = $5,538.

Worked example 2: the pill

One month at 1.5 mg, then 11 months at 4 mg: $149 + 11 × $199 = $149 + $2,189 = $2,338. If you need 9 mg from month three: $149 + $199 + 10 × $299 = $149 + $199 + $2,990 = $3,338.

Where does compounded semaglutide fit if you have type 2 diabetes?

Only with a clinician who knows your diabetes plan. Compounded semaglutide is not FDA-approved. It is made with the drug in Ozempic and Wegovy, but it is not the same product. FDA says the agency "does not review compounded drugs for safety, effectiveness or quality before they are marketed," and that compounded drugs "should only be used in patients whose medical needs cannot be met by an FDA-approved drug."

The price gap is large. Across the 23 compounded semaglutide programs we track that list a rankable price, the lowest all-in monthly figures run from $49 to $179, with a median of $95. NexLife charges $109 month to month or $95 a month on a 12-month plan, the same at every dose, as of November 6, 2026. Eleven of the 23 programs list a lower figure than $95, including Mondae at $87 month to month. Both $49 figures are conditional (a fall-sale price, and an "as low as" figure with no stated term).

A year of Ozempic 1 mg at $4,188 against the median compounded program at $1,140 is a difference of $3,048. That figure leaves out what matters most. Ozempic is FDA-approved to improve blood sugar in adults with type 2 diabetes, and the injection also carries indications to reduce the risk of major cardiovascular events and of worsening kidney disease in certain adults with type 2 diabetes. A compounded product has no FDA-approved label at all.

Other medicines matter too. The Ozempic label warns that people using it with "an insulin secretagogue (e.g., sulfonylurea) or insulin may have an increased risk of hypoglycemia." Any semaglutide product, brand or compounded, belongs in a plan your diabetes clinician has reviewed. Our pages on compounded semaglutide vs Ozempic and compounded semaglutide safety go further, and the NexLife profile lists its plan terms.

What this means for you

• Uninsured, steady on 0.5 mg or 1 mg: budget $349 a month, or $4,188 a year, at NovoCare. At 2 mg, $5,988.
• Uninsured and starting before December 31, 2026: ask about the two $199 fills; your first 12 fills would cost $3,888.
• Open to a daily pill: Ozempic pill 4 mg at $199 is $2,388 a year, or $4,188 − $2,388 = $1,800 less than the pen at $349, if your clinician agrees it suits you. See our Rybelsus and oral semaglutide page.
• On Medicare: the Bridge is not an option with type 2 diabetes. Check your Part D formulary. NovoCare cash is allowed, but it won't count toward your out-of-pocket limit.
• Commercially insured: the $25 card caps savings at $100 a month, so compare your copay minus $100 with $349.
• Weighing compounded semaglutide: treat it as a different product, not a cheaper Ozempic, and decide with the clinician who manages your diabetes.

For the brand side, see our Ozempic page and Ozempic vs Wegovy. For every cash route in one place, see semaglutide without insurance.